Clinical effects are persistent at the end of one abobotulinumtoxinA injection cycle in cervical dystonia – results from a meta-analysis of 1091 subjects
Objective: Evaluate the impact of one injection cycle of abobotulinumtoxinA (AboBoNT-A; Dysport®) on the clinical characteristics of cervical dystonia (CD). Background: The pharmacologic effects of…Clinical Relevance of Treatment With OnabotulinumtoxinA in Patients With Cervical Dystonia: Results From the CD Probe Study
Objective: To explore minimal clinically important change perceived by patients as beneficial by the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) using data from the…How satisfied are cervical dystonia patients with their botulinum toxin treatment? Findings from an international observational study
Objective: Evaluate patient satisfaction with botulinum neurotoxin-A (BoNT-A) treatment over an injection cycle in routine practice. Background: Benefits of BoNT-A injection in cervical dystonia (CD)…Botulinum neurotoxins type A versus B for cervical dystonia in adults – 2016 Cochrane movement disorders group systematic review update
Objective: To update a Cochrane review comparing botulinum neurotoxin type A (BtA) to type B (BtB) in adults with cervical dystonia (CD). Background: This is…AbobotulinumtoxinA for cervical dystonia: International treatment patterns
Objective: To characterise international dosing practice for abobotulinumtoxinA (Dysport®, ABO) for cervical dystonia (CD) in a large observational study. Background: The safety and efficacy of…Botulinum toxin type A therapy for blepharospasm – Update of a Cochrane systematic review and meta-analysis
Objective: To compare the effects of botulinum toxin type A (BtA) versus placebo in blepharospasm. Background: This is an update of a Cochrane systematic review.…Multicentre retrospective chart review of patients treated with incobotulinumtoxinA to evaluate sustained efficacy and tolerability in converted and de-novo conditions
Objective: This study aimed to determine whether IncobotulinumtoxinA (IBTX) provides sustained efficacy as a treatment modality patients in both de-novo patients and patients converted from…Botulinum toxin type B therapy for cervical dystonia – 2015 update of a Cochrane systematic review and meta-analysis
Objective: To compare the effects of botulinum toxin type B (BtB) versus placebo in cervical dystonia (CD). Background: This is an update of a Cochrane…Endoscopic-guided injection of botulinum toxin into the longus capitis muscle and into the obliquus superior part of the longus colli muscle in dystonic antecaput
Objective: Cervical dystonia is the most commonly described dystonia. Since examinations of the muscle using imaging techniques were started [1], the classification of the phenomenological…Efficacy of 4845 botulinum toxin (BoNT) treatment cycles, and clinical strategies after a failed cycle
Objective: To explore 1) relationship between peak benefit and Duration of Adequate Response (DAR) after BoNT, 2) frequency & causes of secondary Treatment Failure (TF),…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.